Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN – Research Report), Qiagen (QGEN – Research Report) and Waters (WAT – Research Report).
Amgen (AMGN)
Bank of America Securities analyst Geoff Meacham maintained a Hold rating on Amgen yesterday and set a price target of $315.00. The company’s shares closed last Tuesday at $316.07, close to its 52-week high of $329.72.
According to TipRanks.com, Meacham is a 4-star analyst with an average return of
Currently, the analyst consensus on Amgen is a Moderate Buy with an average price target of $312.14, implying a -4.1% downside from current levels. In a report issued on January 29, J.P. Morgan also maintained a Hold rating on the stock with a $290.00 price target.
See today’s best-performing stocks on TipRanks >>
Qiagen (QGEN)
J.P. Morgan analyst Casey Woodring maintained a Buy rating on Qiagen yesterday. The company’s shares closed last Tuesday at $44.80.
According to TipRanks.com, Woodring is a 1-star analyst with an average return of
Qiagen has an analyst consensus of Moderate Buy, with a price target consensus of $48.18, which is a 13.4% upside from current levels. In a report issued on January 26, Deutsche Bank also maintained a Buy rating on the stock.
Waters (WAT)
Bank of America Securities analyst Derik De Bruin reiterated a Hold rating on Waters yesterday and set a price target of $338.00. The company’s shares closed last Tuesday at $330.38, close to its 52-week high of $346.24.
According to TipRanks.com, Bruin is a 3-star analyst with an average return of
Waters has an analyst consensus of Hold, with a price target consensus of $296.89, implying a -7.8% downside from current levels. In a report issued on January 29, Robert W. Baird also maintained a Hold rating on the stock with a $289.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AMGN:
